Much of the increase is because of population growth, aging.

Go beyond the lungs because the disease does, too.

Positive and negative psychological status affect CVD health, prognosis.

With SGLT2i vs GLP-1RA use, similar rates of MACE and less HHF, but more adverse events.

Meta-analysis suggests 3% risk increase with each weekly serving.

Mean days alive, out of hospital did not differ with vs without discontinuation.

Risk increase is apparent soon after the MI.

Post-anthracycline statin exposure is linked to reduced HF hospitalization.

Authors offer 3-step algorithm that is fully engaged within 4 weeks.

ACE2 receptor expression may be irrelevant to greater disease severity in adults.

Mortality odds are 10-fold higher with COVID-19 added to HF.

An analysis of 467 patients with CHF attending a routine follow-up visit.

Treatment choice should be based on factors other than QoL.

Editorial: rare cardiomyopathies might not be so rare after all.